Drug intelligence / Profile preview

rGDF11

Development stage
Preclinical
Lead developer
Elevian
Modality
Cytokines & Interferons → Recombinant Proteins and Enzymes
Administration
Intravenous (preclinical Studies)
01

Overview

rGDF11 is the recombinant form of growth differentiation factor 11 (GDF11), a member of the transforming growth factor beta (TGF-β) superfamily. GDF11 is a circulating protein and cytokine involved in cellular development, tissue repair, and regulation of embryological development, particularly in skeletal and nervous systems. Recombinant GDF11 has been developed as a therapeutic candidate for its regenerative properties, including enhancement of neurogenesis, neovascularization, reduction of inflammation, and improvement in sensorimotor function after injury. Preclinical studies have shown that systemic administration of rGDF11 improves outcomes following ischemic and hemorrhagic stroke by promoting vascularization and neural stem cell proliferation. It also shows potential benefits in metabolic disease (obesity/type 2 diabetes), cardiovascular disease, muscle regeneration/aging reversal models[3][4][5][6][8].

Other names
recombinant GDF11recombinant growth differentiation factor 11
02

Targets

TGFBR1ACVR2A (Activin receptor type 2A)ACVR1C (Activin A Receptor Type 1C)ACVR2B (Activin receptor type IIB)ACVR1B (Activin A receptor type IB)

Beyond the preview

Go deeper on rGDF11.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on rGDF11.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call